Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elliot Smith

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Clinical Lung Cancer|February 14, 2021
Subtypes of EGFR- and HER2-Mutant Metastatic NSCLC Influence Response to Immune Checkpoint InhibitorsSally C M Lau, Aline Fusco Fares, Lisa W Le, et al.
Clinical Lung Cancer|February 14, 2021
Systemic Inflammatory Markers of Survival in Epidermal Growth Factor-Mutated Non-Small-Cell Lung Cancer: Single-Institution Analysis, Systematic Review, and Meta-analysisSze Wah Samuel Chan, Elliot Smith, Reenika Aggarwal, et al.
Bone Marrow Transplantation|November 8, 2023
Upfront allogeneic transplantation versus JAK inhibitor therapy for patients with myelofibrosis: a North American collaborative studyDawn Maze, Murat O Arcasoy, Ryan Henrie, et al.
Transplantation and Cellular Therapy|April 2, 2021
Association of Factors Influencing Selection of Upfront Hematopoietic Cell Transplantation versus Nontransplantation Therapies in MyelofibrosisElliot Smith, Jingyue Huang, Auro Viswabandya, et al.
Cancer Medicine|October 26, 2019
Real-world health utility scores and toxicities to tyrosine kinase inhibitors in epidermal growth factor receptor mutated advanced non-small cell lung cancerShirley Xue Jiang, Ryan N Walton, Katrina Hueniken, et al.
Circulation|July 30, 2019
Guiding Principles for Chronic Total Occlusion Percutaneous Coronary InterventionEmmanouil S Brilakis, Kambis Mashayekhi, Etsuo Tsuchikane, et al.
Journal of the American College of Cardiology|August 20, 2021
Global Chronic Total Occlusion Crossing Algorithm: JACC State-of-the-Art ReviewEugene B Wu, Emmanouil S Brilakis, Kambis Mashayekhi, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Clinical Lung Cancer|February 14, 2021
Subtypes of EGFR- and HER2-Mutant Metastatic NSCLC Influence Response to Immune Checkpoint InhibitorsSally C M Lau, Aline Fusco Fares, Lisa W Le, et al.
Clinical Lung Cancer|February 14, 2021
Systemic Inflammatory Markers of Survival in Epidermal Growth Factor-Mutated Non-Small-Cell Lung Cancer: Single-Institution Analysis, Systematic Review, and Meta-analysisSze Wah Samuel Chan, Elliot Smith, Reenika Aggarwal, et al.
Bone Marrow Transplantation|November 8, 2023
Upfront allogeneic transplantation versus JAK inhibitor therapy for patients with myelofibrosis: a North American collaborative studyDawn Maze, Murat O Arcasoy, Ryan Henrie, et al.
Transplantation and Cellular Therapy|April 2, 2021
Association of Factors Influencing Selection of Upfront Hematopoietic Cell Transplantation versus Nontransplantation Therapies in MyelofibrosisElliot Smith, Jingyue Huang, Auro Viswabandya, et al.
Cancer Medicine|October 26, 2019
Real-world health utility scores and toxicities to tyrosine kinase inhibitors in epidermal growth factor receptor mutated advanced non-small cell lung cancerShirley Xue Jiang, Ryan N Walton, Katrina Hueniken, et al.
Circulation|July 30, 2019
Guiding Principles for Chronic Total Occlusion Percutaneous Coronary InterventionEmmanouil S Brilakis, Kambis Mashayekhi, Etsuo Tsuchikane, et al.
Journal of the American College of Cardiology|August 20, 2021
Global Chronic Total Occlusion Crossing Algorithm: JACC State-of-the-Art ReviewEugene B Wu, Emmanouil S Brilakis, Kambis Mashayekhi, et al.
Pageof 5